Share this article on:

HIV sexual transmission risk among serodiscordant couples: assessing the effects of combining prevention strategies

Lasry, Arielle; Sansom, Stephanie L.; Wolitski, Richard J.; Green, Timothy A.; Borkowf, Craig B.; Patel, Pragna; Mermin, Jonathan

doi: 10.1097/QAD.0000000000000307
Epidemiology and Social

Background: The number of strategies to prevent HIV transmission has increased following trials evaluating antiretroviral therapy (ART), preexposure prophylaxis (PrEP) and male circumcision. Serodiscordant couples need guidance on the effects of these strategies alone, and in combination with each other, on HIV transmission.

Methods: We estimated the sexual risk of HIV transmission over 1-year and 10-year periods among male–male and male–female serodiscordant couples. We assumed the following reductions in transmission: 80% from consistent condom use; 54% from circumcision in the negative male partner of a heterosexual couple; 73% from circumcision in the negative partner of a male–male couple; 71% from PrEP in heterosexual couples; 44% from PrEP in male–male couples; and 96% from ART use by the HIV-infected partner.

Findings: For couples using any single prevention strategy, a substantial cumulative risk of HIV transmission remained. For a male–female couple using only condoms, estimated risk over 10 years was 11%; for a male–male couple using only condoms, estimated risk was 76%. ART use by the HIV-infected partner was the most effective single strategy in reducing risk; among male–male couples, adding consistent condom use was necessary to keep the 10-year risk below 10%.

Conclusion: Focusing on 1-year and longer term transmission probabilities gives couples a better understanding of risk than those illustrated by data for a single sexual act. Long-term transmission probabilities to the negative partner in serodiscordant couples can be high, though these can be substantially reduced with the strategic use of preventive methods, especially those that include ART.

Supplemental Digital Content is available in the text

Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Correspondence to Dr Arielle Lasry, Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, 1600 Clifton Road, Mailstop E-48, Atlanta, GA 30333, USA. Tel: +1 404 639 2025; e-mail:

Received 20 November, 2013

Revised 10 April, 2014

Accepted 10 April, 2014

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (

© 2014 Lippincott Williams & Wilkins, Inc.